US Patent 10519136 Dual inhibitors of PARP1 and CDK
Patent 10519136 was granted and assigned to Accutar Biotech on December, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10519136 Dual inhibitors of PARP1 and CDK
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.